Aro Biotherapeutics is a biotechnology company which provides a protein drug platform. Its main product is Centyrins developed for patients with cancer and other serious diseases. The Company offers a program for non-small cell lung cancer and potentially other cancers, including squamous cell carcinoma of the head and neck and gastrointestinal cancer.